|
|
|
Ivan Coulter, Chief Executive Officer
Prior to founding Sigmoid, Dr Coulter set up, developed and managed the drug formulation and diagnostics groups at NTera (www.ntera.com), a nanotechnology-focused, Irish based drug delivery and diagnostics company. Dr Coulter has an honours degree and PhD in Pharmacology from University College Dublin, held a Post-Doctoral Fellowship at the Institut Curie, Paris and, awarded a Fulbright Scholarship, completed an MBA at Cornell University, New York. While at Cornell, Ivan consulted to Nautilus Biotech SA, advising on strategy and its successful Series “A” fund-raising. In addition, he holds a Diploma in Accounting and Finance awarded by the Association of Chartered and Certified Accountants (ACCA).
Alan Kane, Finance Director Alan Kane assumed the role of Finance Director at Sigmoid in 2007. He is also Managing Director of Sentinel Investments (Shannon) Limited, a privately owned Irish company, established in June 1988 and licensed by the Irish Government to trade in a wide range of financial services. The core elements of Sentinel’s business are Structured Finance, Company Management Services and Portfolio Management. In the initial phase of his career Alan qualified as a Chartered Secretary and subsequently trained as an accountant with PriceWaterhouse in Dublin.
Alan McShane (Non-executive Director) Dr McShane is a graduate of University College Dublin (UCD), having received his medical degree in 1976. He carried out extensive laboratory and clinical research, both at UCD and at the John Hopkins University Hospital, Baltimore, Maryland. This research focused on pulmonary response to various noxious chemicals and was published widely in peer reviewed scientific literature. Dr McShane returned to Ireland in 1987 when he was appointed as a consultant anesthetist at St. Vincent’s Hospital, Dublin. At St. Vincent’s, Dr McShane has held a number of key management roles, including Director of the Department of Anesthesiology and Director of the Intensive Care Unit. Alan is a Fellow of the Royal College of Physicians of Ireland and a Fellow of the Faculty of Anaesthetists, Royal College of Surgeons in Ireland.
Michael Sember (Non-executive Director)
Mr. Sember has over 35 years of broad experience working with both public and private pharmaceutical and biotech companies in the U.S. and Europe. He has experience in the areas of R&D, business development, and corporate finance, including involvement with over 100 licensing transactions and corporate acquisitions. Previously Mr. Sember served in senior positions with Marion Laboratories (later Marion Merrell Dow) and Elan Corporation. Mr. Sember has served on the Boards of ten public and private biotech companies and on the advisory boards of several venture capital firms. Mr. Sember received a bachelor's degree from the University of Pittsburgh and a Master of Business Administration degree from Rockhurst University. |
Dublin City University, Dublin 9, Ireland
Created and maintained by WSI